logo
Basic Approaches to Anti-Retroviral Treatment
Acquired Immune Dysfunction in Cats with Experimentally Induced Feline Immunodeficiency Virus Infection
HIV-1 Propagates in Human Neuroblastoma Cells
Marked Elevations of Serum Alkaline Phosphatase in Patients with AIDS
Dapsone as a Single Agent is Suboptimal Therapy for Pneumocystis carinii Pneumonia
Pneumocystis carinii Pneumonia in Patients with AIDS
MRI-Guided Stereotaxic Brain Biopsy in Neurologically Symptomatic AIDS Patients
Effects of Long-Term Zidovudine Treatment on Cell-Mediated Immune Response and Lymphokine Production
Zidovudine Use In AIDS-Free HIV-1-Seropositive Homosexual Men in the Multicenter AIDS Cohort Study (MACS), 1987–1989
A Multicenter Proficiency Trial of Gene Amplification (PCR) for the Detection of HIV-1
HTLV-I-Associated Leukemia/Lymphoma in South Florida
A Cross-Sectional Study of a Program for HIV Infection Control Among Public House Workers
IFN-γ to Treat Patients with AIDS
Authors' Reply
Clinical Trial of Oral Ribavirin
HTLV-I Coinfection in a HIV-1-Infected Peruvian Population
Condom Use Among Transvestites in Italy
Abstracts of a Symposium Sponsored by the University of Miami School of Medicine and the University of California, San Diego
KEYNOTE SPEAKERS
The hemogglutinin and neuraminidase of influenza virus as a model for HIV glycoproteins
ORAL PRESENTATIONS MOLECUIAR PATHOGENSIS
Structure-based design of C2 symmetric inhibitors of HIV-1 protease
The HIV-1 envelope glycoproteins
New insights on HIV-1 replication and pathogensis
Mechanism of action of the HIV-1 Tat protein
Retroviral DNA integration
Genome structure and regulation of HIV-1 expression
Regulation of HIV gene expression by RNA-protein interactions
HIV-1 vif and vpu gene products
Viral and cellular factors in HIV gene regulation
ANIMAL RETROVIRUSES
Use of cloned simian immunodeficiency virus of defined sequence for study of AIDS pathogenesis
Acute retroviral exposure and host immunity
CELLULAR PATHOGENESIS
Antigenic variation of HIV-1
NF-κB and the activation of HIV-1 gene expression
Role of HIV-1 biological vuriability in the pathogenesis of AIDS
HIV
MARKERS OF DISEASE AND THERAPEUTIC RESPONSE
CD4 Cell Response
Quantitation of HIV-1
AZT Resistance
High-titer plasma viremin in acute HIV-1 infection
THERAPEUTIC STRATEGIES
tat inhibitors
Inhibitors of HIV proteinase
Inhibition of HIV-1 replication by a non-nucleoside reverse trunscriptase inhibitor
Hypericin
THERAPEUTIC STRATEGIES
The mechanism of AZT-induced myopathy
The past, present, and future of therapy with nucleosides active against HIV
DDC neuropathy
POSTER PRESENTATIONS
tat transactivation of luciferase — Novel assay for replicating HIV-1
Transcellular transactivation by HTLV-1 Tax protein
Biological activities of synthetic HIV-1 tat and related peptides
Covalent modification of TAR-RNA in Xenopus oocytes
Mutations within the transmeinbrane glycoprotein of HIV-1 that block glycoprotein function
Cooperative trans-activation of HIV-1 LTR by TAT and a TAR RNA-binding protein
Analysis of natural variation in the long terminal repeat of human immunodeficiency virus type 1
PCR-based DNA sequence strategies for the structural analysis of HIV-I isolates and human CD4 polymorphism
Monoclonul antibodies to HIV-1 reverse transcriptase inhibit enzyme activity
Expression of HIV-1 nef protein under control of different promoters
SYMPOSIUM ABSTRACTS
The role of the trunsmembrane glycoprotein of HIV (gp41) in infection of CD4-positive cells
Regulation of NF-κB dependent cytokine gene expression in HIV-1 infected myeloid cells
Mutations in the HIV env gene define two cleavage sites in gp160 that are required for infectivity and pathogenicity
Single amino acid substitutions in the V3 loop region of the HIV-1 gp120 protein alter virus infectivity
Expression of the HIV-1 reverse transcriptase in Spodoptera frugiperda cells
Analysis of the interactions between the components of the initiation complex of HIV-1 reverse transcriptase
Down regulation of interferon-stimulated gene expression by HIV and tumor necrosis factor
Transactivation of the HIV long terminal repent (LTR) by herpes simplex virus type 1 (HSV-I) immediate-early genes
Interferon inhibits the NF-κB-mediated activation of HV-1
In vivo regulation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice
Transcription of HIV-1 regulatory genes in non-productively infected, primary CD4 lymphocytes
A cellular protein is recognized by an anti-idiotypic antibody which mimics the predominant neutralization domain of HIV isolate Bru
A signal mediated via the cytoplasmic domain of the CD4 molecule influences the level of HIV-1 replication
ANIMAL RETROVIRUSES
The role of the primary neutralizing determinant (PND) in protective immunity elicited by HIV vaccines in chimpanzees
Cloning, Expression, and Partial Kinetic Characterization of the Feline Immunodeficiency Virus Proteinase
Construction of zidovudine-resistunt SIVmac variants by site-directed mutagenesis for pathogenesis studies
Variability and expression of feline immunodeficiency virus
CELLULAR PATHOGENESIS
Activation of cytotoxic cells in HIV-1 replicating lymph nodes
In vivo production of cytokines during HIV infection
Regulation of IFN-α in HIV-infected cells
Deficits in T- and B-cell function in mice with a retrovirus
Refolded tut protein protects both bulge and loop nucleotides in TAR RNA from ribonucleolytic cleavage
Macrophages productively infected with HIV resist superinfection by vesicular stomatitis virus (VSV)
SK&K 86002, an inhibitor of TNFα and IL-1 synthesis, significantly reduces the production of HIV-stimulating activity by LPS-activated human monocytes
Kaposi's sarcoma-like cells (KSLC) obtained from peripheral blood of patients with Kaposi's sarcoma
Functional deletion of specific T cells interacting with presenting cells exposed to antigen and to HIV is MHC Class II restricted
Interactions between HIV and mycobacteria in macrophages cultured in vitro
Suppression of HIV-1 replication in CD4+ T-cells by a soluble factor(s) produced by a CD8+ HTLV-1 + cell line
Expression of HIV by latently infected monocyte/ macrophages
Monocyte differentiation induced by rIL-4 interferes with HIV-1 infection
Restricted HIV-1 replication in vivo
A simple colorimetric transactivation-based assay for the detection and titration of infectious HIV-1, HIV-2, and SIV
Study of HIV-1 entry into the central nervous system in vivo using in situ hybridization
Activation of HIV from patients' CD4+ T cells by anti-CD3 and effects of TNF-α
GENETIC AND BIOLOGIC VARIATION
Identification of biologically unique, SIV-like HIV-2 variants in healthy West African individuals
Genetic variability in IIV-1 in individuals infected with related viruses
Genetic mapping of regions in the HIV-1 genome determining syneytium induction und cytotropism
Non-mitogenic T-cell activation signals are sufficient for induction of HIV transcription
Analysis of HIV genomes by multiplex sequencing
CEM Clones not varying in CD4 expression but varying in responses to glucocorticoids differ in susceptibility to HIV-1 infection
Ordered appearance of zidovudine resistance mutations during therapy
Genetic characterization of HIV isolates by the RNuse A mismatch method
Molecular characterization of HIV-1 variants arising after prolonged zidovudine (AZT) therapy
Virological and immunological events early in HIV-1 infection
Generation of highly variant DNA termini during polymerization by HIV-1 reverse transcriptase
Monocytotropic HIV-1 variants, detectable in all stages of HIV-1 infection, predominantly lack T-cell-line tropism and are non-syncytium-inducing in primary T-cell culture
Altered sensitivity to Retrovir (zidovudine, AZT) and dideoxyinosine (DDI) in HIV clinical isolates
MARKERS OF DISEASE AND THERAPEUTIC RESPONSE
Proviruses with mutation causing zidovudine resistance can persist after discontinuation of therapy
Specific PCR detection and DNA sequence analysis of the AZT-resistant RT genotype of HIV-1
Predictors of rapid progression to death after AIDS diagnosis
The transferrin receptor (TfR) in HIV-associated anemia
Nonsteroidal anti-inflammatory drugs decrease CD4 and CD8 levels
The use of self-sustained sequence replication (3SR) amplification and bead-based sandwich hybridization (BBSH) to detect AZT-resistant mutants of HIV-1
Quantitative estimation of HIV proviruses in blood using the polymerase chain reaction (PCR) as a virologic marker
Relative contributions of the initial immune response and immune system activation to the outcome of HIV disease
Quantitative distribution of HIV-1 in plasma, platelets, granulocytes, lymphocytes, and monocytes of infected persons
THERAPEUTIC STRATEGIES
Induction of persistent HIV-1 infection
Novel mechanism of action of nucleoside analogues with anti-HIV activity
Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus
The role of stereotactic biopsy in the management of focal brain lesions in AIDS
Inhibition of HIV infectivity by hypericin
Inhibition of HIV-1 production in patients' PBL by recombinant HIV-like particles
Structure and activity correlation-studies of anti-HIV acyclic guanine nucleotide analogues at enzyme level
Activation of 2′-fluoro-2′,3′-dideoxyarabinosyladenine (FddA), an anti-HIV agent, in both quiescent and PHA-activated human peripheral blood monomiclear cells (PBMC)
Inhibition of zidovudine-resistant HIV-1 isolates in vitro by 2-drug combination regimens
Studies on C2 symmetric inhibitors of HIV-1 protease
Combinations of AZT, dextran sulfate, and phos-phonoformate synergistically inhibit HIV-1 replication in vitro
A sensitive non-isotopic method for the determination of intracellular azidothymidine-5′-mono-, di-, and triphosphate
Statine-based inhibitors of HIV-1 protease effectively block the production of infectious virus progeny in HIV-1-infected T-cells
A novel soluble factor induced by an extract from Pinus parviflora Sieb et Zucc can inhibit the replication of human immunodeficiency virus in vitro
Synthetic inhibitors of HIV-1 protease inhibit virus maturation and infectivity of virions
Retroviral particle inactivation by organic polycyclic quinones
Mechanism of action of oxuthiin carhoxanilide — a potent inhibitor of HIV-1 replication
Inuctivation of retroviral particles by hypericin
L-687,908, a potent hydroxyethylene-containing HIV protease inhibitor
Differential effects of sCD4 and polyanionic compounds on HIV-induced syncytium formation depending on the virus strain and cell type
The inhibition of HIV-1 proviral DNA synthesis in resting PBL by nucleosides
TIBO derivatives are potent inhibitors of HIV-1 reverse transcriptase with heteropolymer templates
New untiretroviral acyclic nucleotide analog
New untiretroviral agent